SEVEN EIGHT CAPITAL, LP - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 161 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$421,00029,2000.11%
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q1 2020.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders